Exchange: NASDAQ·Updated 03:58 PM EDT
XBIO logo

XBIO Xenetic Biosciences Inc

$3.80
$0.01
(0.26%)
Today
Mkt Cap$8.93M
Vol18,518.00

About XBIO

Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.
49

Neutral Sentiment

How do you feel about XBIO?

Advertisement|Remove ads.